aurobindo pharma (GoldmanSachs) USFDA import alert poses medium term overhang, move to Neutral

Date Rating Target Price Recommendation Price Broker house
25 Feb 2011 neutral (from buy) 226 (from 313) 172 GoldmanSachs Report

No comments:

Post a Comment